These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 1709852)

  • 61. Paroxetine in the elderly: a comparative meta-analysis against standard antidepressant pharmacotherapy.
    Dunbar GC
    Pharmacology; 1995 Sep; 51(3):137-44. PubMed ID: 7501698
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antidepressants and the peripheral nervous system.
    Husstedt IW; Kuhs H; Rudolf GA; Brune GG
    Acta Psychiatr Scand Suppl; 1989; 350():147-8. PubMed ID: 2530774
    [No Abstract]   [Full Text] [Related]  

  • 63. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients.
    Byrne MM
    Acta Psychiatr Scand Suppl; 1989; 350():138-9. PubMed ID: 2530768
    [No Abstract]   [Full Text] [Related]  

  • 65. Paroxetine: a selective serotonin reuptake inhibiting antidepressant.
    Caley CF; Weber SS
    Ann Pharmacother; 1993 Oct; 27(10):1212-22. PubMed ID: 8251692
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recent pharmacologic advances in antidepressant therapy for the elderly.
    Preskorn SH
    Am J Med; 1993 May; 94(5A):2S-12S. PubMed ID: 8503477
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differential pharmacology of newer antidepressants.
    DeVane CL
    J Clin Psychiatry; 1998; 59 Suppl 20():85-93. PubMed ID: 9881541
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression.
    Wilde MI; Benfield P
    Drugs; 1995 Mar; 49(3):411-39. PubMed ID: 7774514
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Introduction to the development of paroxetine, a novel antidepressant.
    Lassen JB
    Acta Psychiatr Scand Suppl; 1989; 350():13. PubMed ID: 2530764
    [No Abstract]   [Full Text] [Related]  

  • 70. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical effects of serotonin reuptake inhibitors in the treatment of depressive illness.
    Burrows GD; McIntyre IM; Judd FK; Norman TR
    J Clin Psychiatry; 1988 Aug; 49 Suppl():18-22. PubMed ID: 3045107
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
    Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinically significant drug interactions with antidepressants in the elderly.
    Spina E; Scordo MG
    Drugs Aging; 2002; 19(4):299-320. PubMed ID: 12038880
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy and tolerability of antidepressant therapy in the old-old.
    Finkel SI
    J Clin Psychiatry; 1996; 57 Suppl 5():23-8. PubMed ID: 8647789
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A review of the metabolism and pharmacokinetics of paroxetine in man.
    Kaye CM; Haddock RE; Langley PF; Mellows G; Tasker TC; Zussman BD; Greb WH
    Acta Psychiatr Scand Suppl; 1989; 350():60-75. PubMed ID: 2530793
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The electrocardiogram as a tool for therapeutic monitoring: a critical analysis.
    Guy S; Silke B
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():37-9. PubMed ID: 2258381
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.
    Davis R; Whittington R; Bryson HM
    Drugs; 1997 Apr; 53(4):608-36. PubMed ID: 9098663
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Heel RC; Morley PA; Brogden RN; Carmine AA; Speight TM; Avery GS
    Drugs; 1982 Sep; 24(3):169-206. PubMed ID: 6215240
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Milnacipran: new preparation. Tricyclics remain first-line antidepressants.
    Prescrire Int; 1998 Apr; 7(34):51-3. PubMed ID: 10183385
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.
    Haria M; Fitton A; McTavish D
    Drugs Aging; 1994 Apr; 4(4):331-55. PubMed ID: 8019056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.